The delivery device of SARS-CoV-2 mucosal vaccine matters

被引:0
|
作者
Jian, Fanchong [1 ,2 ,3 ]
Cao, Yunlong [1 ,2 ]
机构
[1] Peking Univ, Biomed Pioneering Innovat Ctr BIOP, Beijing, Peoples R China
[2] Changping Lab, Beijing, Peoples R China
[3] Peking Univ, Coll Chem & Mol Engn, Beijing, Peoples R China
关键词
IMMUNE-RESPONSES;
D O I
10.1038/s41590-024-01950-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mucosal vaccine boosters are expected to enhance protection against SARS-CoV-2 infection. A study now reveals that the delivery device - through either intranasal sprayers or nebulizers - also influences the mucosal immunity and protection efficacy in non-human primates.
引用
收藏
页码:1781 / 1783
页数:3
相关论文
共 50 条
  • [31] The SARS-CoV-2 Vaccine Pipeline: an Overview
    Wen-Hsiang Chen
    Ulrich Strych
    Peter J Hotez
    Maria Elena Bottazzi
    Current Tropical Medicine Reports, 2020, 7 : 61 - 64
  • [32] The SARS-CoV-2 Vaccine Pipeline: an Overview
    Chen, Wen-Hsiang
    Strych, Ulrich
    Hotez, Peter J.
    Bottazzi, Maria Elena
    CURRENT TROPICAL MEDICINE REPORTS, 2020, 7 (02) : 61 - 64
  • [33] A vaccine for SARS-CoV-2: goals and promises
    不详
    ECLINICALMEDICINE, 2020, 24
  • [34] Immunophenotyping of SARS-CoV-2 and vaccine design
    Cimolai, Nevio
    VACCINE, 2022, 40 (30) : 3985 - 3986
  • [35] Modular nanoarray vaccine for SARS-CoV-2
    Zagorski, Karen
    Pandey, Kabita
    Rajaiah, Rajesh
    Olwenyi, Omalla A.
    Bade, Aditya N.
    Acharya, Arpan
    Johnston, Morgan
    Filliaux, Shaun
    Lyubchenko, Yuri L.
    Byrareddy, Siddappa N.
    Nanomedicine: Nanotechnology, Biology, and Medicine, 2022, 46
  • [36] Immunophenotyping of SARS-CoV-2 and vaccine design
    Cimolai, Nevio
    VACCINE, 2022, 40 (29) : 3985 - 3986
  • [37] Effectiveness of an Inactivated SARS-CoV-2 Vaccine
    Wilder-Smith, Annelies
    Mulholland, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 946 - 948
  • [38] Commentary: SARS-CoV-2 in tears: It really matters
    Biswas, Jyotirmay
    Pradhan, Arkaprava
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (12) : 3636 - 3637
  • [39] Esophagitis and SARS-CoV-2 vaccine Vacuna contra la esofagitisy el SARS-CoV-2
    Sriwijitalai, Won
    Wiwanitkit, Viroj
    MEDICINA CLINICA, 2023, 160 (03): : 137 - 137
  • [40] SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
    Adashi, Eli Y.
    Gruppuso, Philip A.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (10) : 1771 - 1773